Deal net: 6 – 10 February 2017

The Global Government Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing government funds.

Atriva Therapeutics, a Germany-based developer of antiviral therapies, has received an undisclosed amount in seed funding co-led by public-private partnership High-Tech Gründerfonds and Stichting Participatie Artriva. A range of private investors also participated in the round, which will support the advancement of the startup’s therapy for influenza into the clinical development stage.

See more from this Government Report: Germany


Copyright Mawsonia Limited 2010. Please don't cut articles from or the PDF and redistribute by email or post to the web without written permission.

Most read

  1. News round up 26 February 2018

    February 26, 2018

  2. News round up 5 March 2018

    March 05, 2018

  3. News round up 12 March 2018

    March 12, 2018

  4. Institutional investors play starring role in $700m Constellation fund

    March 01, 2018

  5. Billon and Signaturit win showcase event

    March 16, 2018